查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1713696

2025年全球腫瘤標記檢測市場報告

Tumor Marker Testing Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年腫瘤標記檢測市場規模將強勁成長。到 2029 年，這一數字將成長至 252.7 億美元，複合年成長率為 8.0%。預測期內的成長可以歸因於人們對癌症早期發現的認知不斷提高、癌症研究資金不斷增加、個人化醫療的擴展、醫療保健支出的增加以及保險覆蓋率的提高。預測期內的關鍵趨勢包括技術進步、產品創新、診斷技術的進步、創新測試解決方案以及策略合作夥伴關係數量的增加。

預計腫瘤標記檢測市場的成長將受到癌症盛行率上升的推動。癌症是一種以異常細胞不受控制地生長為特徵的疾病，它可以侵入附近的組織並透過血液和淋巴系統擴散到全身。癌症發生率的上升是由於人口老化、環境暴露增加、生活方式改變以及檢測和診斷的進步等因素造成的。腫瘤標記測試用於診斷癌症、監測治療反應或透過測量癌細胞產生的某些物質來檢測復發。例如，根據美國癌症協會2023年1月發布的報告，美國癌症新病例1,958,310例，死亡病例609,820例。此外，美國國家醫學圖書館於2021年5月預測，到2040年全球癌症病例將達2,840萬，比2020年增加47%，並造成大量死亡。此類癌症的發生率不斷上升，推動了腫瘤標記檢測市場的成長。

為了保持競爭力，腫瘤標記檢測市場的公司正專注於開發分子檢測解決方案等先進檢測。分子檢測解決方案是一種先進的診斷方法，透過分析遺傳物質（DNA和/或RNA）來在分子層面上檢測突變、病原體和特定的生物標記。例如，2024年4月，專注於個人化癌症治療的瑞士公司RGCC International推出了創新癌症檢測測試Onco-D-clare。該測試結合了分子生物學和人工神經網路，能夠在症狀出現之前及早發現癌症。 Onco-D-clare 從血液樣本中分離周邊血單核細胞，並對 90 多個基因進行全面的基因表現分析。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、新冠疫情、經濟復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球腫瘤標記檢測PESTEL分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球腫瘤標記檢測市場：成長率分析
  • 全球腫瘤標記檢測市場表現：規模與成長，2019-2024
  • 全球腫瘤標記檢測市場預測：規模與成長，2024-2029，2034年
  • 全球腫瘤標記檢測總目標市場（TAM）

第6章市場區隔

  • 全球腫瘤標記檢測市場：依產品、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 生化標記
  • 致癌基因
  • 生長因子
  • 荷爾蒙
  • 集落刺激因子
  • 淋巴激素
  • 免疫組織化學染色法
  • 其他產品
  • 全球腫瘤標記檢測市場（依方法、效能和預測）：2019-2024 年、2024-2029 年、2034 年
  • 篩檢
  • 影像學診斷
  • 治療診斷學
  • 乙狀結腸鏡檢查
  • 其他方法
  • 全球腫瘤標記檢測市場：應用、績效及預測（2019-2024 年、2024-2029 年及 2034 年）
  • 醫院
  • 商業或私人實驗室
  • 醫生辦公室或團體診所
  • 癌症診所
  • 門診治療中心
  • 全球腫瘤標記檢測市場依生化標記類型、表現及預測細分，2019-2024 年、2024-2029 年、2034 年
  • 胎兒球蛋白（AFP）
  • 前列腺特異性抗原（PSA）
  • 癌胚抗原（CEA）
  • 癌抗原125（CA 125）
  • 癌抗原19-9（CA 19-9）
  • 人類絨毛膜促性腺激素分泌（hCG）
  • 全球腫瘤標記檢測市場，依癌症基因類型細分，績效及預測，2019-2024 年、2024-2029 年、2034 年
  • HER2/新
  • KRAS
  • BRAF
  • EGFR（表皮生長因子受體）
  • c-MYC
  • p53
  • 全球腫瘤標記檢測市場按成長因素類型、表現和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 血管內皮生長因子（VEGF）
  • 血小板衍生生長因子（PDGF）
  • 轉化生長因子BETA（TGF-B）
  • 纖維母細胞生長因子（FGF）
  • 胰島素樣生長因子（IGF）
  • 全球腫瘤標記檢測市場依荷爾蒙類型、表現及預測細分，2019-2024 年、2024-2029 年、2034 年
  • 雌激素受體（ER）
  • 孕酮受體（PR）
  • 甲狀腺球蛋白
  • 抑鈣素
  • 促腎上腺皮質激素（ACTH）
  • 胃泌素
  • 全球腫瘤標記檢測市場集落刺激因子細分（按類型、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 顆粒細胞增生因子（G-CSF）
  • 粒細胞-巨噬細胞集落刺激因子（GM-CSF）
  • 巨噬細胞集落刺激因子（M-CSF）
  • 全球腫瘤標記檢測市場按淋巴激素類型、表現和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 白細胞介素-2（IL-2）
  • 干擾素-γ（IFN-Y）
  • 腫瘤壞死因子α（TNF-α）
  • 白細胞介素-6（IL-6）

第7章 區域和國家分析

  • 全球腫瘤標記檢測市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球腫瘤標記檢測市場：依國家、績效及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章競爭格局與公司概況

  • 腫瘤標記檢測市場：競爭格局
  • 腫瘤標記檢測市場：公司簡介
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

  • Becton Dickinson and Company（BD）
  • Quest Diagnostics Inc.
  • Agilent Technologies Inc
  • Hologic Inc.
  • Illumina Inc.
  • bioMerieux SA
  • Bio-Rad Laboratories Inc.
  • Qiagen NV
  • DiaSorin SpA
  • Myriad Genetics
  • Ortho Clinical Diagnostics PLC
  • Veracyte Inc.
  • Biodesix Inc.
  • Biocept Inc.
  • Proteomedix AG

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

  • 2029年腫瘤標記檢測市場：提供新機會的國家
  • 2029年腫瘤標記檢測市場：細分領域帶來新機會
  • 2029年腫瘤標記檢測市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第36章 附錄

簡介目錄
Product Code: r33598

Tumor marker testing involves detecting specific substances, often proteins, that are produced by cancer cells or by the body in response to cancer. These tests are used for diagnosing cancer, monitoring treatment progress, and checking for recurrence. Typically, the tests are conducted on blood, urine, or tissue samples.

Key products in tumor marker testing include biochemical markers, oncogenes, growth factors, hormones, colony-stimulating factors, lymphokines, and immunohistochemical stains, among others. Biochemical markers are measurable substances in the body, such as proteins or enzymes, that indicate biological or pathological processes and are used for diagnosing or tracking diseases. Tumor marker testing is conducted using methods such as screening, imaging, theranostics, and sigmoidoscopy. It is utilized in various settings including hospitals, commercial or private laboratories, physician offices or group practices, cancer clinics, and ambulatory care centers.

The tumor marker testing market research report is one of a series of new reports from The Business Research Company that provides tumor marker testing market statistics, including the tumor marker testing industry's global market size, regional shares, competitors with a tumor marker testing market share, detailed tumor marker testing market segments, market trends and opportunities, and any further data you may need to thrive in the tumor marker testing industry. This tumor marker testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The tumor marker testing market size has grown strongly in recent years. It will grow from $17.18 billion in 2024 to $18.6 billion in 2025 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to increasing cancer prevalence, rising focus on research and development, rising public awareness of cancer screenings, improved healthcare infrastructure, and an aging population.

The tumor marker testing market size is expected to see strong growth in the next few years. It will grow to $25.27 billion in 2029 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to growing awareness of early cancer detection, increasing funding for cancer research, expansion of personalized medicine, increased healthcare expenditure, and improved insurance coverage. Major trends in the forecast period include technological advancements, product innovation, advancement in diagnostic technologies, innovative testing solutions, and increasing strategic collaborations.

The growth of the tumor marker testing market is expected to be driven by the rising prevalence of cancer. Cancer is a disease marked by the uncontrolled growth of abnormal cells that can invade nearby tissues and spread throughout the body via the blood and lymphatic systems. The increase in cancer rates is attributed to factors such as an aging population, greater environmental exposures, lifestyle changes, and advancements in detection and diagnosis. Tumor marker testing is used to diagnose cancer, monitor treatment responses, and detect recurrences by measuring specific substances produced by cancer cells. For example, a report from the American Cancer Society in January 2023 noted that there were 1,958,310 new cancer cases and 609,820 cancer deaths in the United States. Additionally, the National Library of Medicine projected in May 2021 that the global cancer burden would reach 28.4 million cases by 2040, representing a 47% increase from 2020, with a substantial number of deaths. This increasing prevalence of cancer is driving the growth of the tumor marker testing market.

Companies in the tumor marker testing market are focusing on developing advanced tests, such as molecular testing solutions, to stay competitive. Molecular testing solutions are sophisticated diagnostic methods that analyze genetic material (DNA or RNA) to detect mutations, pathogens, or specific biomarkers at a molecular level. For instance, in April 2024, RGCC International GmbH, a Swiss company specializing in personalized cancer treatment, introduced Onco-D-clare, an innovative cancer detection test. This test enables early cancer detection before symptoms appear by combining molecular biology with artificial neural networks. Onco-D-clare isolates peripheral blood mononuclear cells from blood samples and performs a comprehensive gene expression analysis across more than 90 genes.

In June 2023, Quest Diagnostics, a US-based clinical laboratory, acquired Haystack Oncology for $300 million. This acquisition is intended to improve cancer diagnostics by integrating advanced minimal residual disease (MRD) testing technology. Furthermore, it not only enhances Quest's diagnostic capabilities but also seeks to offer more personalized and effective cancer care solutions through innovative liquid biopsy technology. Haystack Oncology is a biotechnology company based in the United States.

Major companies operating in the tumor marker testing market are Thermo Fisher Scientific Inc., Abbott Laboratories, F. Hoffmann-La Roche AG, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company (BD), Quest Diagnostics Inc., Agilent Technologies Inc, Hologic Inc., Illumina Inc., bioMerieux SA, Bio-Rad Laboratories Inc., Qiagen N.V., DiaSorin S.p.A., Myriad Genetics, Ortho Clinical Diagnostics PLC, Veracyte Inc., Biodesix Inc., Biocept Inc., Proteomedix AG, OncoCyte Corporation, Biocartis NV

North America was the largest region in the tumor marker testing market in 2024. The regions covered in the tumor marker testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the tumor marker testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The tumor marker testing market consists of revenues earned by entities by providing services such as genetic testing, prostate-specific antigen (PSA) tests, and dehydrogenase (LDH) tests. The market value includes the value of related goods sold by the service provider or included within the service offering. The tumor marker testing market also includes sales of test kits, instrumentation, consumables, and reagents. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Tumor Marker Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on tumor marker testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for tumor marker testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The tumor marker testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Biochemical Markers; Oncogenes; Growth Factors; Hormones; Colony Stimulating Factors; Lymphokines; Immunohistochemical Stains; Other Products
  • 2) By Methods: Screening; Imaging; Theranostics; Sigmoidoscopy; Other Methods
  • 3) By Application: Hospitals; Commercial Or Private Laboratories; Physician Offices Or Group Practices; Cancer Clinics; Ambulatory Care Centers
  • Subsegments:
  • 1) By Biochemical Markers: Alpha-fetoprotein (AFP); Prostate-Specific Antigen (PSA); Carcinoembryonic Antigen (CEA); Cancer Antigen 125 (CA 125); Cancer Antigen 19-9 (CA 19-9); Human Chorionic Gonadotropin (hCG)
  • 2) By Oncogenes: HER2/neu; KRAS; BRAF; EGFR (Epidermal Growth Factor Receptor); c-MYC; p53
  • 3) By Growth Factors: Vascular Endothelial Growth Factor (VEGF); Platelet-Derived Growth Factor (PDGF); Transforming Growth Factor-beta (TGF-B); Fibroblast Growth Factor (FGF); Insulin-like Growth Factor (IGF)
  • 4) By Hormones: Estrogen Receptors (ER); Progesterone Receptors (PR); Thyroglobulin; Calcitonin; Adrenocorticotropic Hormone (ACTH); Gastrin
  • 5) By Colony Stimulating Factors: Granulocyte Colony-Stimulating Factor (G-CSF); Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF); Macrophage Colony-Stimulating Factor (M-CSF)
  • 6) By Lymphokines: Interleukin-2 (IL-2); Interferon-gamma (IFN-Y); Tumor Necrosis Factor-alpha (TNF-a); Interleukin-6 (IL-6)
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Abbott Laboratories; F. Hoffmann-La Roche AG; Danaher Corporation; Siemens Healthineers AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Tumor Marker Testing Market Characteristics

3. Tumor Marker Testing Market Trends And Strategies

4. Tumor Marker Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Tumor Marker Testing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Tumor Marker Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Tumor Marker Testing Market Growth Rate Analysis
  • 5.4. Global Tumor Marker Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Tumor Marker Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Tumor Marker Testing Total Addressable Market (TAM)

6. Tumor Marker Testing Market Segmentation

  • 6.1. Global Tumor Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Biochemical Markers
  • Oncogenes
  • Growth Factors
  • Hormones
  • Colony Stimulating Factors
  • Lymphokines
  • Immunohistochemical Stains
  • Other Products
  • 6.2. Global Tumor Marker Testing Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Screening
  • Imaging
  • Theranostics
  • Sigmoidoscopy
  • Other Methods
  • 6.3. Global Tumor Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Commercial Or Private Laboratories
  • Physician Offices Or Group Practices
  • Cancer Clinics
  • Ambulatory Care Centers
  • 6.4. Global Tumor Marker Testing Market, Sub-Segmentation Of Biochemical Markers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Alpha-fetoprotein (AFP)
  • Prostate-Specific Antigen (PSA)
  • Carcinoembryonic Antigen (CEA)
  • Cancer Antigen 125 (CA 125)
  • Cancer Antigen 19-9 (CA 19-9)
  • Human Chorionic Gonadotropin (hCG)
  • 6.5. Global Tumor Marker Testing Market, Sub-Segmentation Of Oncogenes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • HER2/neu
  • KRAS
  • BRAF
  • EGFR (Epidermal Growth Factor Receptor)
  • c-MYC
  • p53
  • 6.6. Global Tumor Marker Testing Market, Sub-Segmentation Of Growth Factors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Vascular Endothelial Growth Factor (VEGF)
  • Platelet-Derived Growth Factor (PDGF)
  • Transforming Growth Factor-beta (TGF-B)
  • Fibroblast Growth Factor (FGF)
  • Insulin-like Growth Factor (IGF)
  • 6.7. Global Tumor Marker Testing Market, Sub-Segmentation Of Hormones, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Estrogen Receptors (ER)
  • Progesterone Receptors (PR)
  • Thyroglobulin
  • Calcitonin
  • Adrenocorticotropic Hormone (ACTH)
  • Gastrin
  • 6.8. Global Tumor Marker Testing Market, Sub-Segmentation Of Colony Stimulating Factors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Granulocyte Colony-Stimulating Factor (G-CSF)
  • Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)
  • Macrophage Colony-Stimulating Factor (M-CSF)
  • 6.9. Global Tumor Marker Testing Market, Sub-Segmentation Of Lymphokines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Interleukin-2 (IL-2)
  • Interferon-gamma (IFN-Y)
  • Tumor Necrosis Factor-alpha (TNF-a)
  • Interleukin-6 (IL-6)

7. Tumor Marker Testing Market Regional And Country Analysis

  • 7.1. Global Tumor Marker Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Tumor Marker Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Tumor Marker Testing Market

  • 8.1. Asia-Pacific Tumor Marker Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Tumor Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Tumor Marker Testing Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Tumor Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Tumor Marker Testing Market

  • 9.1. China Tumor Marker Testing Market Overview
  • 9.2. China Tumor Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Tumor Marker Testing Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Tumor Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Tumor Marker Testing Market

  • 10.1. India Tumor Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Tumor Marker Testing Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Tumor Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Tumor Marker Testing Market

  • 11.1. Japan Tumor Marker Testing Market Overview
  • 11.2. Japan Tumor Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Tumor Marker Testing Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Tumor Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Tumor Marker Testing Market

  • 12.1. Australia Tumor Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Tumor Marker Testing Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Tumor Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Tumor Marker Testing Market

  • 13.1. Indonesia Tumor Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Tumor Marker Testing Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Tumor Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Tumor Marker Testing Market

  • 14.1. South Korea Tumor Marker Testing Market Overview
  • 14.2. South Korea Tumor Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Tumor Marker Testing Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Tumor Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Tumor Marker Testing Market

  • 15.1. Western Europe Tumor Marker Testing Market Overview
  • 15.2. Western Europe Tumor Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Tumor Marker Testing Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Tumor Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Tumor Marker Testing Market

  • 16.1. UK Tumor Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Tumor Marker Testing Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Tumor Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Tumor Marker Testing Market

  • 17.1. Germany Tumor Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Tumor Marker Testing Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Tumor Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Tumor Marker Testing Market

  • 18.1. France Tumor Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Tumor Marker Testing Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Tumor Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Tumor Marker Testing Market

  • 19.1. Italy Tumor Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Tumor Marker Testing Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Tumor Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Tumor Marker Testing Market

  • 20.1. Spain Tumor Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Tumor Marker Testing Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Tumor Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Tumor Marker Testing Market

  • 21.1. Eastern Europe Tumor Marker Testing Market Overview
  • 21.2. Eastern Europe Tumor Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Tumor Marker Testing Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Tumor Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Tumor Marker Testing Market

  • 22.1. Russia Tumor Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Tumor Marker Testing Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Tumor Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Tumor Marker Testing Market

  • 23.1. North America Tumor Marker Testing Market Overview
  • 23.2. North America Tumor Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Tumor Marker Testing Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Tumor Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Tumor Marker Testing Market

  • 24.1. USA Tumor Marker Testing Market Overview
  • 24.2. USA Tumor Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Tumor Marker Testing Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Tumor Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Tumor Marker Testing Market

  • 25.1. Canada Tumor Marker Testing Market Overview
  • 25.2. Canada Tumor Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Tumor Marker Testing Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Tumor Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Tumor Marker Testing Market

  • 26.1. South America Tumor Marker Testing Market Overview
  • 26.2. South America Tumor Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Tumor Marker Testing Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Tumor Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Tumor Marker Testing Market

  • 27.1. Brazil Tumor Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Tumor Marker Testing Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Tumor Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Tumor Marker Testing Market

  • 28.1. Middle East Tumor Marker Testing Market Overview
  • 28.2. Middle East Tumor Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Tumor Marker Testing Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Tumor Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Tumor Marker Testing Market

  • 29.1. Africa Tumor Marker Testing Market Overview
  • 29.2. Africa Tumor Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Tumor Marker Testing Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Tumor Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Tumor Marker Testing Market Competitive Landscape And Company Profiles

  • 30.1. Tumor Marker Testing Market Competitive Landscape
  • 30.2. Tumor Marker Testing Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

31. Tumor Marker Testing Market Other Major And Innovative Companies

  • 31.1. Becton Dickinson and Company (BD)
  • 31.2. Quest Diagnostics Inc.
  • 31.3. Agilent Technologies Inc
  • 31.4. Hologic Inc.
  • 31.5. Illumina Inc.
  • 31.6. bioMerieux SA
  • 31.7. Bio-Rad Laboratories Inc.
  • 31.8. Qiagen N.V.
  • 31.9. DiaSorin S.p.A.
  • 31.10. Myriad Genetics
  • 31.11. Ortho Clinical Diagnostics PLC
  • 31.12. Veracyte Inc.
  • 31.13. Biodesix Inc.
  • 31.14. Biocept Inc.
  • 31.15. Proteomedix AG

32. Global Tumor Marker Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Tumor Marker Testing Market

34. Recent Developments In The Tumor Marker Testing Market

35. Tumor Marker Testing Market High Potential Countries, Segments and Strategies

  • 35.1 Tumor Marker Testing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Tumor Marker Testing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Tumor Marker Testing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
  • 250423_r33598_Tumor_Marker_Testing_GMR_2025